Profluent

Company R&D

Profluent’s Neural Network Model Designs High-Efficiency CRISPR Gene-Editing System

Fineline Cube May 8, 2024

Biotechnology company Profluent has announced a significant advancement in the field of gene editing with...

Policy / Regulatory

U.S. Tariffs on Pharmaceuticals and Their Impact on China’s Medical Industry

Company Drug

Sichuan Biokin Launches Phase III Trial for BL-B01D1 in Urothelial Carcinoma

Company Drug

AbbVie’s Rinvoq Approved in EU for Giant Cell Arteritis

Company Drug

Bristol-Myers Squibb’s Opdivo/Yervoy Combo Approved for MSI-H Colorectal Cancer